The insurance industry, which holds billions of yuan of investment assets, is actively looking for investment opportunities in the A-share market. According to the latest statistics of Shanghai Securities News, since November this year, 105 insurance institutions have investigated 239 A-share listed companies, and the research enthusiasm is still high. By the end of October this year, the scale of insurance assets was about 24.44 trillion yuan, and the balance of fund utilization was about 22.58 trillion yuan.
From the survey data, the technology and pharmaceutical sectors have been most favored by insurance companies recently. In addition, with the support of policies, specialized and new “little giant” enterprises have attracted the attention of the market, and the insurance enterprises with huge capital have also focused their research on such enterprises with low market value and high growth. From the survey data, the industries of mechanical equipment, medicine and biology, electronics, chemical industry and electrical equipment are most concerned by insurance companies, which have attracted more than 20 insurance companies to conduct research.
Recently, the research of insurance enterprises has been nonstop. Since November, 105 insurance institutions have investigated 239 listed companies.
China Insurance Asset Management Association and China Life Insurance Company Limited(601628) recently organized a “questionnaire survey of 100 people in asset management”. 73% of the more than 100 asset management leaders participating in the survey said they were optimistic about a shares.
The investment manager of a large insurance asset management company said that from the perspective of short-term layout, he would pay attention to thematic opportunities such as vaccines and covid-19 drugs in the near future and temporarily avoid relevant sectors represented by offline consumer services.
If the observation period is extended to next year, Xing Yi, deputy general manager and chief investment officer of Taikang assets, said that in terms of stock market investment strategy, we need to take into account growth and value, adhere to the combination of meso top-down and micro bottom-up, grasp the growth opportunities represented by big health, new energy, science and technology, consumption and other sectors, and return to the attractive range The value direction of good medium and long-term fundamentals.
Affected by the favorable policies, institutional investors began to explore investment opportunities for specialized new “little giant” enterprises, and insurance enterprises are also actively arranging.
Statistics show that in October this year, there were more than 70 enterprises with a market value of no more than 10 billion yuan. Since November, 90 small and medium-sized enterprises with market value have been investigated by insurance enterprises. Among them, Shanghai Aladdin Biochemical Technology Co.Ltd(688179) , Chengdu Guibao Science & Technology Co.Ltd(300019) and other specialized new “little giant” concept stocks have been investigated by insurance companies.
According to the 2022 investment strategy report released by Citic Securities Company Limited(600030) , from the position of public funds, the over allocation proportion of A-share specialized special new “little giant” has increased rapidly since 2021, and there is still much room. In the A-share market, most of the specialized new “little giant” enterprises have a market value of less than 10 billion yuan, and most of them belong to manufacturing sectors such as machinery, basic chemical industry, electronics, power equipment and new energy.
Insurance funds pursue steady returns and prefer leading enterprises in investment layout. From the data, the research of insurance companies on leading stocks in each segment has not stopped. Among the 239 listed companies surveyed, Shenzhen Farben Information Technology Co.Ltd(300925) , Thunder Software Technology Co.Ltd(300496) , Bank Of Ningbo Co.Ltd(002142) , Chongqing Fuling Zhacai Group Co.Ltd(002507) and other high-quality stocks were investigated by 22, 20, 18 and 16 insurance companies respectively.
(Shanghai Securities News)
